
CARGO Therapeutics, Inc. Common Stock – NASDAQ:CRGX
CARGO Therapeutics, Inc. Common Stock stock price today
CARGO Therapeutics, Inc. Common Stock stock price monthly change
CARGO Therapeutics, Inc. Common Stock stock price quarterly change
CARGO Therapeutics, Inc. Common Stock stock price yearly change
CARGO Therapeutics, Inc. Common Stock key metrics
Market Cap | 662.56M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -3.03 |
Revenue | N/A |
EBITDA | -116.34M |
Income | -121.21M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCARGO Therapeutics, Inc. Common Stock stock price history
CARGO Therapeutics, Inc. Common Stock stock forecast
CARGO Therapeutics, Inc. Common Stock financial statements
Jun 2023 | 0 | -17.85M | |
---|---|---|---|
Sep 2023 | 0 | -35.47M | |
Dec 2023 | 0 | -32.07M | |
Mar 2024 | 0 | -35.81M |
2024-03-21 | -1.62 | -1.49 |
---|---|---|
2024-05-14 | -1.05 | -0.87 |
2024-08-12 | -1.06 | -1.02 |
Jun 2023 | 60497000 | 135.47M | 223.94% |
---|---|---|---|
Sep 2023 | 82412000 | 191.74M | 232.67% |
Dec 2023 | 453036000 | 47.65M | 10.52% |
Mar 2024 | 422429000 | 49.21M | 11.65% |
Jun 2023 | -14.90M | -1.49M | 2K |
---|---|---|---|
Sep 2023 | -23.21M | -3.90M | 45.09M |
Dec 2023 | -28.98M | -2.97M | 377.91M |
Mar 2024 | -30.14M | -293.95M | -104K |
CARGO Therapeutics, Inc. Common Stock alternative data
Dec 2023 | 74 |
---|---|
Jan 2024 | 42 |
Feb 2024 | 42 |
Mar 2024 | 116 |
Apr 2024 | 116 |
May 2024 | 116 |
Jun 2024 | 123 |
Jul 2024 | 123 |
CARGO Therapeutics, Inc. Common Stock other data
-
What's the price of CARGO Therapeutics, Inc. Common Stock stock today?
One share of CARGO Therapeutics, Inc. Common Stock stock can currently be purchased for approximately $4.51.
-
When is CARGO Therapeutics, Inc. Common Stock's next earnings date?
Unfortunately, CARGO Therapeutics, Inc. Common Stock's (CRGX) next earnings date is currently unknown.
-
Does CARGO Therapeutics, Inc. Common Stock pay dividends?
No, CARGO Therapeutics, Inc. Common Stock does not pay dividends.
-
How much money does CARGO Therapeutics, Inc. Common Stock make?
CARGO Therapeutics, Inc. Common Stock has a market capitalization of 662.56M. CARGO Therapeutics, Inc. Common Stock made a loss 98.15M US dollars in net income (profit) last year or -$1.02 on an earnings per share basis.
-
What is CARGO Therapeutics, Inc. Common Stock's stock symbol?
CARGO Therapeutics, Inc. Common Stock is traded on the NASDAQ under the ticker symbol "CRGX".
-
What is CARGO Therapeutics, Inc. Common Stock's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of CARGO Therapeutics, Inc. Common Stock?
Shares of CARGO Therapeutics, Inc. Common Stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does CARGO Therapeutics, Inc. Common Stock have?
As Jul 2024, CARGO Therapeutics, Inc. Common Stock employs 123 workers, which is 6% more then previous quarter.
-
When CARGO Therapeutics, Inc. Common Stock went public?
CARGO Therapeutics, Inc. Common Stock is publicly traded company for just a year since IPO on 13 Nov 2023.
-
What is CARGO Therapeutics, Inc. Common Stock's official website?
The official website for CARGO Therapeutics, Inc. Common Stock is cargo-tx.com.
-
How can i contact CARGO Therapeutics, Inc. Common Stock?
CARGO Therapeutics, Inc. Common Stock can be reached via phone at +65 03796143.
CARGO Therapeutics, Inc. Common Stock company profile:

CARGO Therapeutics, Inc. Common Stock
cargo-tx.comNASDAQ
170
Biotechnology
Healthcare
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.
San Mateo, 94403
CIK: 0001966494
ISIN: US14179K1016
CUSIP: 14179K101